Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹1000
-
Expense Ratio
2.47
-
NAV
₹10.19
-
Fund Started
19 Nov 2024
-
Fund Size
₹85.19 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
-
1 Year
7.22%
-
3 Year
-
-
5 Year
-
-
Equity
97.20%
-
Cash
-0.76%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.41% |
Divi's Laboratories Ltd. | 10.01% |
Aster DM Healthcare Ltd. | 7.51% |
JB Chemicals & Pharmaceuticals Ltd. | 6.98% |
Max Healthcare Institute Ltd. | 5.56% |
Rubicon Research Ltd. | 5.44% |
Ajanta Pharma Ltd. | 5.02% |
Mankind Pharma Ltd. | 4.96% |
Dr. Reddy's Laboratories Ltd. | 3.95% |
Krishna Institute of Medical Sciences Ltd | 3.81% |
-
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
19 Nov 2024
-
